ShockWave Medical (NASDAQ:SWAV) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:03 PM.
Here’s what investors need to know about the announcement.
Earnings
ShockWave Medical beat estimated earnings by 34.83%, reporting an EPS of $1.2 versus an estimate of $0.89.
Revenue was up $58.95 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.13 which was followed by a 17.08% drop in the share price the next day.
Here’s a look at ShockWave Medical’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.79 | 0.87 | 0.81 | 1 |
| EPS Actual | 0.92 | 0.76 | 1.03 | 3.71 |
| Revenue Estimate | 184.72M | 173.30M | 147.31M | 142.60M |
| Revenue Actual | 186.02M | 180.16M | 161.07M | 144.03M |
To track all earnings releases for ShockWave Medical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
